Rephonic
Artwork for BioSpace

BioSpace

BioSpace
FDA
Clinical Trials
Eli Lilly
Novo Nordisk
Pfizer
Glp-1
Gene Therapy
Drug Development
Artificial Intelligence
Women's Health
Biopharma
Johnson & Johnson
Merck
China
Inflation Reduction Act
Duchenne Muscular Dystrophy
Sarepta
Job Market
Astrazeneca
Women In Clinical Trials

Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.

PublishesDailyEpisodes224Founded2 years ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for BioSpace

Latest Episodes

In this episode of Denatured, you'll be hearing from Dr. Sarah Howell, CEO at Arecor Therapeutics and Dr. Wendy S. Lane, clinical endocrinologist and diabetologist. We examine how increasingly connected and tailored diabetes technologies are reframin... more

After entering the CAR T arena in February, Eli Lilly jumped onto the in vivo bandwagon, penning a deal worth up to $7 billion for Kelonia Therapeutics and its gene therapy delivery tech iGPS. Meanwhile, Belgium-based UCB scooped up Neurona Therapeut... more

In this episode of Denatured, you'll be hearing from Edoardo Negroni, co-founder & managing partner at AurorA-TT and Naveed Siddiqi, senior partner, Venture Investments at Novo Holdings. We debate whether Europe’s world-class science can be matched b... more

Johnson & Johnson kicked off Q1 earnings season with a “modest” beat, raking in $24.1 billion in sales as it targets $100 billion in revenue in 2026. J&J, as always, is the first to report results from a first quarter that has seen a wave of deals ac... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
Big Take
Big TakeBloomberg and iHeartPodcasts

Recent Guests

Dr. Sarah Howell
CEO of Arecor Therapeutics
Arecor Therapeutics
Episode: The next era of diabetes management
Dr. Wendy Lane
Clinical Endocrinologist and diabetologist
Mountain Diabetes and Endocrine Center
Episode: The next era of diabetes management
Ryan Watts
CEO of Denali Therapeutics, discussed Denali's Hunter syndrome approval
Denali Therapeutics
Episode: Trump’s psychedelics push, Lilly’s up to $7B CAR T deal, Replimune’s saga and Denali’s big win
Naveed Siddiqi
Senior Partner, Venture Investments at Novo Holdings
Novo Holdings
Episode: Funding the Future of European Biotech
Edoardo Negroni
Co-Founder and Managing Partner at AurorA-TT
AurorA-TT
Episode: Funding the Future of European Biotech
Jason Jones
Head of Global Business Development at Cellular Origins
Cellular Origins
Episode: Automation, Collaboration and the Future of Advanced Therapies
Alexander Seyf
Founder and CEO of Autolomous
Autolomous
Episode: Automation, Collaboration and the Future of Advanced Therapies
Sabrina Martucci Johnson
CEO of DARE Bioscience
DARE Bioscience
Episode: Lilly’s Foundayo Nod Launches New Battle With Novo, M&A Mania Continues, Tariffs Hit Pharma
Phil Kantoff
CEO and co-founder of Convergent Therapeutics
Episode: The Radiotherapeutics Moment: How Isotopes are Changing Cancer Treatment

Hosts

Jennifer Smith-Parker
Director of Insights at BioSpace; Host/Editor with emphasis on financing and policy in biopharma.
Heather McKenzie
Host of BioSpace's The Weekly; Senior Editor focusing on industry trends and regulatory updates.

Reviews

4.7 out of 5 stars from 31 ratings
  • informative and lively

    Love the podcast. The roundtable discussions are engaging, informative, and lively. The information shared helps keep me current in the biopharma industry.

    Apple Podcasts
    5
    AudraStar
    United States7 months ago
  • Great content, the sound quality needs to improve

    The topics discussed are relevant and interesting. The sound quality needs to improve, especially normalizing the volume of the different speakers and using better microphones to avoid saturation.

    Apple Podcasts
    4
    MarcoMtt
    United Statesa year ago
  • Love this podcast

    Love this pod, keep up the good work!

    Apple Podcasts
    5
    Ddxbsbabs
    United States2 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Engaging and informative with lively roundtable discussions.
Sound quality varies; volume normalization could improve.
Positive feedback on content and guests, strong overall sentiment.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

The next era of diabetes management
Q: What are the main barriers to pump adoption, especially for type 2 diabetes, and how might future tech address them?
Barriers include high burden and cost of consumables, limited 7-day wear due to insulin cartridge constraints, payer coverage issues, and clinical inertia; future solutions point to smaller, longer-wear, integrated systems that reduce manual input and increase reliability.
The next era of diabetes management
Q: What is the current state of diabetes technology and how does it translate to day-to-day living for patients?
There have been significant advancements in CGMs, pumps, and algorithms, but the day-to-day burden remains high as patients still must manage timing, dosing, and device interactions; the lived experience involves balancing technology with real-life activities and ensuring devices work reliably.
Bonus: Q1 2026 Job Market Update
Q: What happened to the biopharma job market so far this year?
Overall postings were fairly flat year over year, but monthly gains suggest the market may be turning a corner, with increased activity in February and March and a notable uptick in contract positions versus full-time roles.
Lilly’s Foundayo Nod Launches New Battle With Novo, M&A Mania Continues, Tariffs Hit Pharma
Q: Can you explain Foundayo's positioning in the obesity drug space and how it compares to Wigoby?
Foundayo appears to differ from Wigoby primarily in administration and dosing flexibility, which could influence daily use and patient adherence; initial trial signals suggest there are nuanced efficacy differences, but without a direct head-to-head, the debate centers on real-world uptake and patient convenience.
Beyond Buzzwords in Longevity Investing
Q: What does the regulatory and commercialization path look like today for a startup marketed as longevity-focused?
The path relies on a disease-specific target with clear mechanisms and endpoints, FDA alignment, and a comprehension of how payers will require outcome-based evidence; broader aging claims come later, once a solid regulatory and commercial foundation has been established.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BioSpace

What is BioSpace about and what kind of topics does it cover?

The show concentrates on the financial and strategic side of biopharma, frequently unpacking non-dilutive funding, family-office involvement, and biotech financing strategies. Episodes balance market-wide dynamics—FDA decisions, regulatory shifts, and fundraising climates—with deep dives into company-level financing, leadership changes, and major therapeutic areas such as ALS, cardiovascular disease, obesity, oncology, and neuroscience. A notable strength is the blend of investor and operator perspectives, including financial officers, strategy consultants, and C-suite executives from biotech and pharma, which helps listeners understand both capital markets and development timelines. The program is likely to appeal to senior biotech executi... more

Where can I find podcast stats for BioSpace?

Rephonic provides a wide range of podcast stats for BioSpace. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BioSpace and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BioSpace get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for BioSpace, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BioSpace?

Rephonic provides comprehensive predictive audience data for BioSpace, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BioSpace have?

To see how many followers or subscribers BioSpace has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BioSpace?

These podcasts share a similar audience with BioSpace:

1. BioCentury This Week
2. The Readout Loud
3. Biotech Hangout
4. The Long Run with Luke Timmerman
5. Big Take

How many episodes of BioSpace are there?

BioSpace launched 2 years ago and published 224 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BioSpace?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BioSpace?

Rephonic pulls ratings and reviews for BioSpace from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BioSpace?

Rephonic provides full transcripts for episodes of BioSpace. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BioSpace?

Recent guests on BioSpace include:

1. Dr. Sarah Howell
2. Dr. Wendy Lane
3. Ryan Watts
4. Naveed Siddiqi
5. Edoardo Negroni
6. Jason Jones
7. Alexander Seyf
8. Sabrina Martucci Johnson

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days